Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Nanosci Nanotechnol ; 18(10): 6791-6798, 2018 10 01.
Article in English | MEDLINE | ID: mdl-29954495

ABSTRACT

In the ancient traditional Indian Ayurvedic system of natural healing, gold nanoparticles (Swarna Bhasma, gold ash) have been used for its therapeutic benefits as far back as 2500 B.C. Ayurvedic medicinal preparations are complex mixtures that include many plant-derived products and metals. Bhasmas date as far back as the 8th century and are made by samskaras (processings), such as shodhana (purification and potentiation), jarana (roasting), and marana (incineration, trituration) in the presence of plant products, including juices and concoctions. Previous studies characterized the physical properties of gold ash, and the mechanisms of its entry into human cells, but only preliminary data exist on its toxicity. Before using nanoparticles for therapeutic application, it is extremely important to study their toxicity and cellular internalization. In the present study, various imaging techniques were used to investigate Swarna Bhasma's (gold nanopowder) toxicity in both cancerous and noncancerous cells (HeLa and HFF-1) and to characterize its spectral properties. The results showed that gold ash particles had no impact on the cellular viability of both HeLa and HFF-1 cells, even at high concentrations or long incubation times. Moreover, it was found that the internalization level of Swarna Bhasma to cells may be improved by mechanical breaking of the large aggregates into smaller agglomerates. Hyperspectral images revealed that after breaking, the small agglomerates have different spectral properties in cells, compared to the original aggregates, suggesting that size of particles is instrumental for the subcellular interaction with human cells.


Subject(s)
Gold/pharmacology , Gold/pharmacokinetics , Latex/pharmacology , Latex/pharmacokinetics , Arsenic/adverse effects , Arsenic/pharmacokinetics , Arsenic/pharmacology , Calotropis/adverse effects , Cell Line , Cell Survival/drug effects , Drug Combinations , Gold/adverse effects , HeLa Cells , Humans , Latex/adverse effects , Lead/adverse effects , Lead/pharmacokinetics , Lead/pharmacology , Medicine, Ayurvedic , Metal Nanoparticles/adverse effects , Particle Size
SELECTION OF CITATIONS
SEARCH DETAIL
...